Search

Bharat Aggarwal

from Dublin, CA
Age ~42
Get Report
Related to:
Charu C Aggarwal, 47Ravnish Gupta, 49Reema Gupta, 46Alok O Gupta, 50Donna K Isom, 61Aditi Aggarwal, 46Vijay GuptaRavi K Gupta, 71Nitin Gupta, 49Parag Gupta, 44
Connected to:
Abhuday Aggarwal, 47Aditya K Aggarwal, 90Akhilesh Aggarwal, 41Amitesh Aggarwal, 48Amrit Aggarwal, 70Anoop Aggarwal, 28Anu Aggarwal, 57Ashwani K Aggarwal, 66Bindeshwari I Aggarwal, 77

Bharat Aggarwal Phones & Addresses

  • 11203 Rolling Hills Dr, Dublin, CA 94568
  • Sacramento, CA
  • Fremont, CA
  • San Francisco, CA
  • Alameda, CA

Work

Company: Toyota fremont and toyota sunnyvale Dec 2011 Position: Direct sales and finance manager

Education

School / High School: Golden Gate University- San Francisco, CA May 2011 Specialities: Masters in Taxation Law

Resumes

Resumes

Bharat Aggarwal Photo 1

Senior Executive Stores At Hardeo Group

View page
Position:
Sr.Executive Stores at Hardeo Group
Location:
Sangrur, Punjab, India
Industry:
Wine and Spirits
Work:
Hardeo Group since Apr 2012
Sr.Executive Stores
Trident LTD - Barnala (Punjab) Feb 2007 - Apr 2012
FLE Supply Chain Management
Nestle India LTD Feb 2007 - Feb 2010
Trainee
Education:
IGNOU 2007 - 2011
Bachelor's degree, Arts Arihant Institute of Engineering & Technology 2006 - 2007
Diploma, Material Management Arihant Institute of Engineering & Technology
Diploma, Material Management IGNOU
Bachelor of Arts TPM
Post Graduate Diploma, Business Management
Skills:
Windows
Microsoft Word
Microsoft Office
Microsoft Excel
Customer Service
PowerPoint
Budgets
Outlook
English
Social Media
Strategic Planning
Negotiation
Public Speaking
Research
Teamwork
Team Leadership
Project Management
SAP
Languages:
English
Hindi
Punjabi
Bharat Aggarwal Photo 2

Bharat Aggarwal

View page
Location:
United States
Bharat Aggarwal Photo 3

Bharat Aggarwal

View page
Work:
Toyota Fremont and Toyota Sunnyvale

Dec 2011 to 2000
Direct Sales and Finance Manager
Nishith Desai Associates
Palo Alto, CA
Jan 2009 to Dec 2011
Assistant Manager, Business Development
PricewaterhouseCoopers
New Delhi, Delhi
Jul 2006 to Jul 2008
Assistant Manager, Indirect Taxes
Deloitte Haskins and Sells
Mumbai, Maharashtra
Feb 2006 to Jul 2006
Assistant Manager, Indirect Taxes
Vikas Singh

May 2005 to Feb 2006
former Additional Solicitor
Education:
Golden Gate University
San Francisco, CA
May 2011
Masters in Taxation Law
University of Pune
Pune, Maharashtra
May 2005
Bachelors in Law
University of Pune
Pune, Maharashtra
May 2003
Bachelors in Business and Legal Studies
The Lawrence School
Feb 1994 to Feb 2000

Publications

Wikipedia References

Bharat Aggarwal Photo 4

Bharat Aggarwal

Isbn (Books And Publications)

Tumor Necrosis Factors: Structure, Function, and Mechanism of Action

View page
Author

Bharat B. Aggarwal

ISBN #

0824785541

Resveratrol in Health And Disease

View page
Author

Bharat B. Aggarwal

ISBN #

0849333717

Human Cytokines: Handbook for Basic and Clinical Research

View page
Author

Bharat B. Aggarwal

ISBN #

0865421838

Human Cytokines: Their Role in Disease and Therapy

View page
Author

Bharat B. Aggarwal

ISBN #

0865423520

Human Cytokines: Handbook for Basic and Clinical Research

View page
Author

Bharat B. Aggarwal

ISBN #

0865424411

Human Cytokines: Handbook for Basic and Clinical Research

View page
Author

Bharat B. Aggarwal

ISBN #

0865425337

Us Patents

Tumor Necrosis Factor

View page
US Patent:
6686455, Feb 3, 2004
Filed:
Jan 18, 1995
Appl. No.:
08/375052
Inventors:
Bharat B. Aggarwal - San Mateo CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A63J 100
US Classification:
530412, 530416, 530422, 530415, 530351
Abstract:
A cytotoxic protein designated tumor necrosis factor is identified in nature. It is recovered in substantially homogeneous form by treatment with hydrophobic substances and ion exchange resins. The protein is conclusively identified by its amino acid sequences. Therapeutic compositions are provided.

Recombinant Lymphotoxin Cdna And Variants

View page
US Patent:
58245090, Oct 20, 1998
Filed:
May 19, 1995
Appl. No.:
8/444653
Inventors:
Bharat B. Aggarwal - San Mateo CA
Patrick W. Gray - San Francisco CA
Glenn E. Nedwin - Guilford CT
Assignee:
Genentech, Inc. - S. San Francisco CA
International Classification:
C12N 1519
C07K 14475
C07K 14495
US Classification:
435 695
Abstract:
Biologically active lymphotoxin polypeptides are synthesized in recombinant cell culture. Novel nucleic acid and vectors incorporating same are provided. The compositions and processes herein enable the economical preparation of compositions containing uniform lymphotoxin polypeptides and variant lymphotoxins having amino acid sequences that differ from those found in nature. The lymphotoxins are purified to a specific activity of 2-10. times. 10. sup. 7 units/mg of protein by purification using a novel immobilized, lymphotoxin-neutralizing monoclonal antibody.

Human Lymphotoxin

View page
US Patent:
49201964, Apr 24, 1990
Filed:
Feb 6, 1987
Appl. No.:
7/011448
Inventors:
Bharat B. Aggarwal - San Mateo CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07G 700
A61K 4505
C12N 500
US Classification:
530351
Abstract:
Biologically active lymphotoxin polypeptide species, and derivatives, fragments, aggregates and pharmaceutically acceptable salts are provided. The lymphotoxins are substantially homogenous, and are formulated into pharmaceutical compositions. The lymphotoxins are purified to a specific activity of at least 10. sup. 6 units/mg protein by using hydrophobic substances and/or immobilized lentil lectin, or with the use of other chromatographic processes such as ion exchange chromatography, HPLC or gel filtration.

Tumor Necrosis Factor Antagonists And Their Use

View page
US Patent:
56723474, Sep 30, 1997
Filed:
May 5, 1995
Appl. No.:
8/435934
Inventors:
Bharat B. Aggarwal - San Mateo CA
Michael A. Palladino - San Mateo CA
Mohamed R. Shalaby - San Rafael CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39395
US Classification:
4241391
Abstract:
Tumor necrosis factor antagonists are administered in therapeutically effective doses to suppress inflammatory immune-potentiated events. The antagonists of this invention typically are selected from among several classes but preferably are neutralizing antibodies directed against tumor necrosis factor. The antagonists are useful in suppressing transplantation immunity and in the treatment of autoimmune diseases.

Tumor Necrosis Factor Antagonists And Their Use

View page
US Patent:
57959676, Aug 18, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/482226
Inventors:
Bharat B. Aggarwal - San Mateo CA
Michael A. Palladino - San Mateo CA
Mohamed R. Shalaby - San Rafael CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 1600
C12N 506
A61K 39395
US Classification:
53038823
Abstract:
Tumor necrosis factor antagonists are administered in therapeutically effective doses to suppress inflammatory immune-potentiated events. The antagonists of this invention typically are selected from among several classes but preferably are neutralizing antibodies directed against tumor necrosis factor. The antagonists are useful in suppressing transplantation immunity and in the treatment of autoimmune diseases.

Synergistic Cytotoxic Composition

View page
US Patent:
46506748, Mar 17, 1987
Filed:
Dec 3, 1984
Appl. No.:
6/677257
Inventors:
Bharat B. Aggarwal - San Mateo CA
Sang He Lee - El Granada CA
Assignee:
Genentech, Inc. - So. San Francisco CA
International Classification:
A61K 4502
C12P 2100
US Classification:
424 85
Abstract:
Compositions comprising an interferon and a cytotoxic protein designated tumor necrosis factor exhibit a synergistic cytotoxic effect on tumor cells.

Recombinant Lymphotoxin

View page
US Patent:
61775436, Jan 23, 2001
Filed:
Mar 19, 1998
Appl. No.:
9/044495
Inventors:
Bharat B. Aggarwal - San Mateo CA
Patrick W. Gray - San Francisco CA
Glenn E. Nedwin - Guilford CT
Assignee:
Genentech, Inc. - So. San Francisco CA
International Classification:
C07K 100
A61K 4505
C12N 506
US Classification:
530351
Abstract:
Biologically active lymphotoxin polypeptides are synthesized in recombinant cell culture. Novel nucleic acid and vectors incorporating same are provided. The compositions and processes herein enable the economical preparation of compositions containing uniform lymphotoxin polypeptides and variant lymphotoxins having amino acid sequences that differ from those found in nature. The lymphotoxins are purified to a specific activity of 2-10. times. 10. sup. 7 units/mg of protein by purification using a novel immobilized, lymphotoxin-neutralizing monoclonal antibody.

Unglycosylated Recombinant Human Lymphotoxin Polypeptides And Compositions

View page
US Patent:
56836880, Nov 4, 1997
Filed:
Feb 14, 1992
Appl. No.:
7/836765
Inventors:
Bharat B. Aggarwal - San Mateo CA
Patrick W. Gray - San Francisco CA
Glenn E. Nedwin - Guilford CT
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3819
C07K 1452
C07K 14525
US Classification:
424 851
Abstract:
Biologically active lymphotoxin polypeptides are synthesized in recombinant cell culture. Novel nucleic acid and vectors incorporating same are provided. The compositions and processes herein enable the economical preparation of compositions containing uniform lymphotoxin polypeptides and variant lymphotoxins having amino acid sequences that differ from those found in nature. The lymphotoxins are purified to a specific activity of 2-10. times. 10. sup. 7 units/mg of protein by purification using a novel immobilized, lymphotoxin-neutralizing monoclonal antibody.
Control profile
Bharat Aggarwal from Dublin, CA, age ~42 Get Report